L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
-
![L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1) structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/f11132ff7a2c4da8a1eb12f38a46a78d.png "L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)")
L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
structure -
-
CAS No:
81919-14-4
-
Formula:
C16H14N2O3.C6H14N2O2
-
Chemical Name:
L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
-
Synonyms:
L-Lysine,2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1);L-Lysine,mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate];Acetic acid,[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-,compd. with L-lysine (1:1);Bendazac L-lysine salt;Bendazac lysine salt;Bendaline;AF 1934;Bendazac lysine;82576-52-1
- Categories:
-
CAS No:
Description
Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1) Basic Attributes
428.48
428.205963
617-268-5
2942000000
L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1) Use and Manufacturing
Antiinflammatory.
Drug Function and Efficacy
Aldose reductase (AR) inhibitors, which inhibit the activity of AR in the lens, are used to prevent or treat cataracts
Registered Holders
-
Lesheng Pharmaceutical Shijiazhuang Co., Ltd.
Active
China
-
Kangya of Ningxia Pharmaceutical Co., Ltd.
Active
China
-
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Active
China
Learn More Other Chemicals
-
L-Lysine, N2-benzoyl-, methyl ester, monohydrochloride
14280-01-4
-
L-Lysine, N2-acetyl-, methyl ester, hydrochloride (1:1)
20911-93-7
-
L-Lysine, N2-[(1,1-dimethylethoxy)carbonyl]-N6-[(phenylmethoxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
16948-04-2
-
L-Lysine, N2-[(1-[1,1′-biphenyl]-4-yl-1-methylethoxy)carbonyl]-N6-[(1,1-dimethylethoxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1) Formula
18635-01-3
-
L-Lysine, 2-[[2-(ethoxycarbonyl)-4-oxo-4H-1-benzopyran-5-yl]oxy]-1-[[[2-(ethoxycarbonyl)-4-oxo-4H-1-benzopyran-5-yl]oxy]methyl]ethyl ester Formula
110816-79-0
-
L-Lysine, 1,2-dithiolane-3-pentanoate (1:1) Formula
20902-53-8
-
L-Lysine, N2-(hydroxymethyl)-, calcium salt (2:1) Structure
75195-63-0
-
L-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(2-propen-1-yloxy)carbonyl]-, compd. with N-cyclohexylcyclohexanamine (1:1) Structure
110637-53-1
-
What is L-Lysine, N2-[8-[[(3.beta.)-3-hydroxy-28-oxolup-20(29)-en-28-yl]amino]-1-oxooctyl]-
150840-62-3
-
What is L-Lysine, ethyl ester, hydrochloride (1:2)
3844-53-9
L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
SDSRequest for Quotation